Magnesium alloy ZK60 shows great promise as a medical metal material, but its corrosion resistance in the body is inadequate. Hydroxyapatite (HA), the primary inorganic component of human and animal bones, can form chemical bonds with body tissues at the interface, promoting the deposition of phosphorus products and creating a dense calcium and phosphorus layer. To enhance the properties of ZK60, HA was added to create HA/ZK60 composite materials. These composites, fabricated using the advanced technique of LPBF, demonstrated superior corrosion resistance and enhanced bone inductive capabilities compared to pristine ZK60. Notably, the incorporation of 3 wt% led to a significant reduction in bulk porosity, achieving a value of 0.8%. The Ecorr value increased from -1.38 V to -1.32 V, while the minimum Icorr value recorded at 33.9 μA·cm-2. Nano-HA achieved the lowest volumetric porosity and optimal corrosion resistance. Additionally, these composites significantly promoted osteogenic differentiation in bone marrow stromal cells (BMSCs), as evidenced by increased alkaline phosphatase (ALP) activity and robust calcium nodule formation, highlighting their excellent biocompatibility and osteo-inductive potential. However, when increasing the HA content to 6 wt%, the bulk porosity rose significantly to 3.3%. The Ecorr value was -1.3 V, with the Icorr value being approximately 50 μA·cm-2. This increase in porosity and weaker interfacial bonding, ultimately accelerated electrochemical corrosion. Therefore, a carefully balanced amount of HA significantly enhances the performance of the ZK60 magnesium alloy, while excessive amounts can be detrimental.
Read full abstract